{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:35:18Z","timestamp":1789504518959,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Australian Institute of Tropical Health and Medicine","award":["13122014"],"award-info":[{"award-number":["13122014"]}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"crossref","award":["2127835"],"award-info":[{"award-number":["2127835"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health and Medical Research Council, Australia","award":["1109035"],"award-info":[{"award-number":["1109035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prevalence of lymphatic filariasis (LF) antigen in American Samoa was 16.5% in 1999. Seven rounds of mass drug administration (MDA) programmes between 2000 and 2006 reduced antigen prevalence to 2.3%. The most efficient methods of surveillance after MDA are not clear, but testing specific at-risk groups such as adults may provide earlier warning of resurgence. The role of migration from LF endemic countries in maintaining transmission also needs investigation. Few studies have investigated knowledge about LF and how that relates to infection risk. This study aims to investigate associations between socio-demographics, population mobility, disease knowledge and LF infection risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In 2014, we surveyed 670 adults aged 16\u201368\u00a0years (62% female) at two worksites in American Samoa. Sera were tested for LF antigen and antibodies (Bm14 and Wb123) by rapid test and\/or ELISA. Multivariate logistic regression was used to assess association between seromarkers and demographic factors, household socioeconomic status (SES), residence, travel history, and knowledge of LF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 1.8% of participants were positive for antigen, 11.8% for Bm14, 11.3% for Wb123 and 17.3% for at least one antibody. Recent travel outside American Samoa was not associated with positivity for any seromarker. Men had higher seroprevalence than women for all outcomes (any antibody: adjusted odds ratio (aOR)\u2009=\u20093.49 (95% CI: 2.21\u20135.49). Those aged over 35 years (compared to 15\u201324 years) had higher prevalence of Bm14 antibody (aOR\u2009=\u20093.75, 3.76 and 4.17 for ages 35\u201344, 45\u201354 and \u2265\u200955\u00a0years, respectively, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Lower SES was associated with seropositivity (antigen: aOR\u2009=\u20092.89, 95% CI: 1.09\u20137.69; either antibody: aOR\u2009=\u20091.51, 95% CI: 1.12\u20132.05). Those who knew that mosquitoes transmitted LF had lower Wb123 antibody prevalence (aOR\u2009=\u20090.55, 95% CI: 0.32\u20130.95).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Opportunistic sampling of adults at worksites provided an efficient and representative way to assess prevalence and risk factors for LF in American Samoa and in hindsight, foreshadowed the resurgence of transmission. Risk of LF infection, detected by one or more serological markers, was not related to recent travel history, but was strongly associated with male gender, older age, lower SES, and lack of knowledge about mosquito transmission. These results could guide future efforts to increase MDA participation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13071-020-3996-4","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T14:02:50Z","timestamp":1584021770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-3901","authenticated-orcid":false,"given":"Patricia M.","family":"Graves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saipale","family":"Fuimaono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"3996_CR1","unstructured":"Department of Commerce of American Samoa Government. American Samoa Statistical Yearbook. 2015. http:\/\/doc.as.gov\/wp-content\/uploads\/2011\/06\/2015-Statistical-Yearbook.pdf. Accessed 20 Sept 2019."},{"key":"3996_CR2","doi-asserted-by":"publisher","first-page":"10136","DOI":"10.1038\/s41598-018-28081-x","volume":"8","author":"Z Xu","year":"2018","unstructured":"Xu Z, Lau C, Zhou X, Fuimaono S, Soares Magalh\u00e3es RJ, Graves PM. The extensive networks of frequent population mobility in the Samoan Islands and their implications for infectious disease transmission. Sci Rep. 2018;8:10136.","journal-title":"Sci Rep"},{"key":"3996_CR3","unstructured":"WHO. Regional Office for the Western Pacific. The PacELF way: towards elimination of lymphatic filariasis in the Pacific. Manila: World Health Organization; 2006. https:\/\/iris.wpro.who.int\/handle\/10665.1\/10966. Accessed 26 Jan 2020."},{"key":"3996_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4269\/ajtmh.2009.80.774","volume":"80","author":"EW Chambers","year":"2009","unstructured":"Chambers EW, McClintock SK, Avery MF, King JD, Bradley MH, Schmaedick MA, et al. Xenomonitoring of Wuchereria bancrofti and Dirofilaria immitis infections in mosquitoes from American Samoa: trapping considerations and a comparison of polymerase chain reaction assays with dissection. Am J Trop Med Hyg. 2009;80:774\u201381.","journal-title":"Am J Trop Med Hyg"},{"key":"3996_CR5","doi-asserted-by":"publisher","first-page":"e3087","DOI":"10.1371\/journal.pntd.0003087","volume":"8","author":"MA Schmaedick","year":"2014","unstructured":"Schmaedick MA, Koppel AL, Pilotte N, Torres M, Williams SA, Dobson SL, et al. Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa. PLoS Negl Trop Dis. 2014;8:e3087.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.4269\/ajtmh.1969.18.369","volume":"18","author":"F Ciferri","year":"1969","unstructured":"Ciferri F, Siliga N, Long G, Kessel JF. A filariasis control programme in American Samoa. Am J Trop Med Hyg. 1969;18:369.","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl. 1","key":"3996_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.actatropica.2010.08.021","volume":"120","author":"JD King","year":"2011","unstructured":"King JD, Zielinski-Gutierrez E, Pa\u2019au M, Lammie P. Improving community participation to eliminate lymphatic filariasis in American Samoa. Acta Trop. 2011;120(Suppl. 1):48\u201354.","journal-title":"Acta Trop"},{"key":"3996_CR8","volume-title":"Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. WHO\/HTM\/NTD\/PCT\/2011.4","author":"WHO","year":"2011","unstructured":"WHO. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. WHO\/HTM\/NTD\/PCT\/2011.4. Geneva: World Health Organization; 2011."},{"key":"3996_CR9","doi-asserted-by":"publisher","first-page":"e0006347","DOI":"10.1371\/journal.pntd.0006347","volume":"12","author":"KY Won","year":"2018","unstructured":"Won KY, Robinson K, Hamlin KL, Tufa J, Seespesara M, Wiegand RE, et al. Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa. PLoS Negl Trop Dis. 2018;12:e0006347.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s41182-017-0063-8","volume":"45","author":"SP Coutts","year":"2017","unstructured":"Coutts SP, King JD, Pa\u2019au M, Fuimaono S, Roth J, King MR, et al. Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration. Trop Med Health. 2017;45:22.","journal-title":"Trop Med Health"},{"key":"3996_CR11","doi-asserted-by":"publisher","first-page":"e3297","DOI":"10.1371\/journal.pntd.0003297","volume":"8","author":"CL Lau","year":"2014","unstructured":"Lau CL, Won K, Becker L, Soares Magalhaes R, Fuimaono S, Melrose W, et al. Seroprevalence and spatial epidemiology of lymphatic filariasis in American Samoa after successful mass drug administration. PLoS Negl Trop Dis. 2014;8:e3297.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR12","doi-asserted-by":"publisher","first-page":"e0005914","DOI":"10.1371\/journal.pntd.0005914","volume":"11","author":"CL Lau","year":"2017","unstructured":"Lau CL, Sheridan S, Ryan S, Roineau M, Andreosso A, Fuimaono S, et al. Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration. PLoS Negl Trop Dis. 2017;11:e0005914.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR13","doi-asserted-by":"publisher","first-page":"e0006583","DOI":"10.1371\/journal.pntd.0006583","volume":"12","author":"M Sheel","year":"2018","unstructured":"Sheel M, Sheridan S, Gass K, Won K, Fuimaono S, Kirk M, et al. Identifying residual transmission of lymphatic filariasis after mass drug administration: comparing school-based versus community-based surveillance\u2014American Samoa, 2016. PLoS Negl Trop Dis. 2018;12:e0006583.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR14","unstructured":"WHO. Department of Control of Neglected Tropical Diseases. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. In: King J, editor. Geneva: World Health Organization; 2017."},{"key":"3996_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4269\/ajtmh.18-0169","volume":"99","author":"RU Rao","year":"2018","unstructured":"Rao RU, Samarasekera SD, Nagodavithana KC, Goss CW, Punchihewa MW, Dassanayaka TDM, et al. Comprehensive assessment of a hotspot with persistent bancroftian filariasis in coastal Sri Lanka. Am J Trop Med Hyg. 2018;99:735\u201342.","journal-title":"Am J Trop Med Hyg"},{"key":"3996_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41182-017-0047-8","volume":"45","author":"T Allen","year":"2017","unstructured":"Allen T, Taleo F, Graves PM, Wood P, Taleo G, Baker MC, et al. Impact of the lymphatic filariasis control program towards elimination of filariasis in Vanuatu, 1997\u20132006. Trop Med Health. 2017;45:8.","journal-title":"Trop Med Health"},{"key":"3996_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1179\/2047773211Y.0000000008","volume":"105","author":"H Joseph","year":"2011","unstructured":"Joseph H, Maiava F, Naseri T, Silva U, Lammie P, Melrose W. Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa. Ann Trop Med Parasitol. 2011;105:567\u201378.","journal-title":"Ann Trop Med Parasitol"},{"key":"3996_CR18","doi-asserted-by":"publisher","first-page":"e0005108","DOI":"10.1371\/journal.pntd.0005108","volume":"10","author":"CL Lau","year":"2016","unstructured":"Lau CL, Won KY, Lammie PJ, Graves PM. Lymphatic filariasis elimination in American Samoa: evaluation of molecular xenomonitoring as a surveillance tool in the endgame. PLoS Negl Trop Dis. 2016;10:e0005108.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4269\/ajtmh.2009.09-0115","volume":"81","author":"BH Lambdin","year":"2009","unstructured":"Lambdin BH, Schmaedick MA, McClintock S, Roberts J, Gurr NE, Marcos K, et al. Dry season production of filariasis and dengue vectors in American Samoa and comparison with wet season production. Am J Trop Med Hyg. 2009;81:1013\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"3996_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3201\/eid1902.120464","volume":"19","author":"J Duncombe","year":"2013","unstructured":"Duncombe J, Lau C, Weinstein P, Aaskov J, Rourke M, Grant R, et al. Seroprevalence of dengue in American Samoa, 2010. Emerg Infect Dis. 2013;19:324\u20136.","journal-title":"Emerg Infect Dis"},{"key":"3996_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.4269\/ajtmh.19-0309","volume":"101","author":"LE Adams","year":"2019","unstructured":"Adams LE, Martin SW, Lindsey NP, Lehman JA, Rivera A, Kolsin J, et al. Epidemiology of dengue, chikungunya, and Zika virus disease in the U.S. states and territories, 2017. Am J Trop Med Hyg. 2019;101:884\u201390.","journal-title":"Am J Trop Med Hyg"},{"key":"3996_CR22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.15585\/mmwr.mm6747a5","volume":"67","author":"CJ Cotter","year":"2018","unstructured":"Cotter CJ, Tufa AJ, Johnson S, Matai\u2019a M, Sciulli R, Ryff KR. Outbreak of dengue virus type 2\u2014American Samoa, November 2016-October 2018. MMWR Morb Mortal Wkly Rep. 2018;67:1319\u201322.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3996_CR23","unstructured":"United States Census Bureau. Census Population and Housing Tables; Population, Housing Units, Land Area, and Density for U.S. Island Areas: 2010 Table\u00a01a. Population, Housing Units, Land Area, and Density by District and Island and County for American Samoa. 2010. https:\/\/www.census.gov\/population\/www\/cen2010\/cph-t\/t-8tables\/table1a.pdf. Accessed 20 Sept 2019."},{"key":"3996_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/heapol\/czl029","volume":"21","author":"S Vyas","year":"2006","unstructured":"Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan. 2006;21:459\u201368.","journal-title":"Health Policy Plan"},{"key":"3996_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41182-017-0057-6","volume":"45","author":"F Taleo","year":"2017","unstructured":"Taleo F, Taleo G, Graves PM, Wood P, Kim SH, Ozaki M, et al. Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu. Trop Med Health. 2017;45:18.","journal-title":"Trop Med Health"},{"key":"3996_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41182-019-0141-1","volume":"47","author":"CN Carlingford","year":"2019","unstructured":"Carlingford CN, Melrose W, Mokoia G, Graves PM, Ichimori K, Capuano C, et al. Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999\u20132016. Trop Med Health. 2019;47:20.","journal-title":"Trop Med Health"},{"key":"3996_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s41182-019-0169-2","volume":"47","author":"R Ofanoa","year":"2019","unstructured":"Ofanoa R, Ofa T, Padmasiri EA, Kapa DR. Elimination of lymphatic filariasis as a public health problem from Tonga. Trop Med Health. 2019;47:43.","journal-title":"Trop Med Health"},{"key":"3996_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4269\/ajtmh.2008.78.924","volume":"78","author":"JL Liang","year":"2008","unstructured":"Liang JL, King JD, Ichimori K, Handzel T, Pa\u2019au M, Lammie PJ. Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa. Am J Trop Med Hyg. 2008;78:924\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"3996_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4269\/ajtmh.2009.80.769","volume":"80","author":"JM Mladonicky","year":"2009","unstructured":"Mladonicky JM, King JD, Liang JL, Chambers E, Pa\u2019au M, Schmaedick MA, et al. Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa. Am J Trop Med Hyg. 2009;80:769\u201373.","journal-title":"Am J Trop Med Hyg"},{"key":"3996_CR30","doi-asserted-by":"publisher","first-page":"e0007365","DOI":"10.1371\/journal.pntd.0007365","volume":"13","author":"R Rao","year":"2019","unstructured":"Rao R, Samarasekera SD, Nagodavithana KC, Punchihewa MW, Ranasinghe USB, Weil GJ. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka. PLoS Negl Trop Dis. 2019;13:e0007365.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR31","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1371\/journal.pntd.0000640","volume":"4","author":"A Boyd","year":"2010","unstructured":"Boyd A, Won KY, McClintock SK, Donovan CV, Laney SJ, Williams SA, et al. A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti. PLoS Negl Trop Dis. 2010;4:e640.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR32","doi-asserted-by":"publisher","first-page":"e0006994","DOI":"10.1371\/journal.pntd.0006994","volume":"13","author":"C Minetti","year":"2019","unstructured":"Minetti C, Tettevi EJ, Mechan F, Prada JM, Idun B, Biritwum NK, et al. Elimination within reach: a cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana. PLoS Negl Trop Dis. 2019;13:e0006994.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13071-019-3428-5","volume":"12","author":"CB Chesnais","year":"2019","unstructured":"Chesnais CB, Awaca-Uvon NP, Vlaminck J, Tambwe JP, Weil GJ, Pion SD, et al. Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo. Parasites Vectors. 2019;12:162.","journal-title":"Parasites Vectors"},{"key":"3996_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1017\/S0950268800047932","volume":"105","author":"L Brabin","year":"1990","unstructured":"Brabin L. Sex differentials in susceptibility to lymphatic filariasis and implications for maternal child immunity. Epidemiol Infect. 1990;105:335\u201353.","journal-title":"Epidemiol Infect"},{"key":"3996_CR35","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3389\/fgene.2019.01282","volume":"10","author":"S Hedtke","year":"2020","unstructured":"Hedtke S, Kuesel AC, Crawford K, Graves P, Boussinesq M, Lau C, et al. Genomic epidemiology in filarial nematodes: transforming the basis for elimination program decisions. Front Genet. 2020;10:1282.","journal-title":"Front Genet"},{"key":"3996_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.epidem.2018.12.003","volume":"27","author":"Z Xu","year":"2019","unstructured":"Xu Z, Graves PM, Lau CL, Clements A, Geard N, Glass K. GEOFIL: a spatially-explicit agent-based modelling framework for predicting the long-term transmission dynamics of lymphatic\u00a0filariasis\u00a0in American Samoa. Epidemics. 2019;27:19\u201327.","journal-title":"Epidemics"},{"key":"3996_CR37","doi-asserted-by":"publisher","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7:e2447.","journal-title":"PLoS Negl Trop Dis"},{"key":"3996_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1471-2334-14-168","volume":"14","author":"GS Noland","year":"2014","unstructured":"Noland GS, Graves PM, Sallau A, Eigege A, Emukah E, Patterson AE, et al. Malaria prevalence, anemia and baseline intervention coverage prior to mass net distributions in Abia and Plateau States, Nigeria. BMC Inf Dis. 2014;14:168.","journal-title":"BMC Inf Dis"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-020-3996-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T01:11:13Z","timestamp":1615511473000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-3996-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-3996-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"28 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approvals were granted by the American Samoa Institutional Review Board, and the Human Research Ethics Committees at James Cook University (H5519) and The University of Queensland (2014000409). The study was conducted in collaboration with the American Samoa Department of Health. Verbal and written information were provided to all participants in Samoan or English according to the participant\u02bcs preference. Signed informed consent forms were obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}